Pharmaceuticals, Biotechnology and Life Sciences
MEDFORD, Mass.–(BUSINESS WIRE)–Solu Therapeutics, a biotechnology company focused on developing therapeutics to eliminate disease-driving cells using its CyTaCTM (Cytotoxicity Targeting…
– Data presented at Mitochondrial Medicine Therapeutic Development (MMTD) annual conference demonstrated ARCUS’ ability to efficiently eliminate mutant mitochondrial DNA…
– Pivotal Phase 3 SAPPHIRE trial in patients with Spinal Muscular Atrophy on track to report topline data in 4Q…
Ad hoc announcement pursuant to Art. 53 LR MILAN–(BUSINESS WIRE)–$NWRN #schizophrenia–Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical…
Includes actinium-based clinical-stage radioconjugate targeting PSMA for prostate cancer, pipeline of radioconjugates and state-of-the-art R&D and manufacturing facilities WILMINGTON, Del.–(BUSINESS…
NEW YORK–(BUSINESS WIRE)–IFF (NYSE: IFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions…
Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners…
DUBLIN–(BUSINESS WIRE)–The “USA Patient Registry Software Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering. The United States…
SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, solidifies its stature as a…
Using NVIDIA Technology, SonoSAMTrack¹ demonstrates its pliability and applicability in ultrasound image segmentation, consistently delivering high-quality results over a wide…